Navigation Links
Experimental approach may improve healing of diabetic wounds and bed sores
Date:2/8/2011

MAYWOOD, Ill. -- Loyola University Health System researchers are reporting on a promising new approach to treating diabetic wounds, bed sores, chronic ulcers and other slow-to-heal wounds.

It may be possible to speed healing by suppressing certain immune system cells, researchers wrote in the February, 2011, issue of the journal Expert Review of Dermatology.

The cells are called neutrophils and natural killer T (NKT) cells. These white blood cells act to kill bacteria and other germs that can infect wounds. NKT cells also recruit other white blood cells to the site of injury. But in some cases, these NKT cells can do more harm than good, said senior author Elizabeth Kovacs, PhD, director of research in Loyola's Burn & Shock Trauma Institute.

Neutrophils can be beneficial to wound healing by gobbling up harmful bacteria and debris such as dead cells. But neutrophils also can do harm -- by producing enzymes that digest healthy surrounding tissue, leading to excessive scar tissue and slower healing.

"It's a balancing act. You need neutrophils, but not too many of them," said Aleah Brubaker, first author of the article and an MD/PhD student at Loyola University Chicago Stritch School of Medicine. The third co-author is Dr. David Schneider, a surgical resident at Loyola.

NKT cells respond to wound injuries by producing proteins called cytokines and chemokines that attract neutrophils and other white blood cells to the wound site. A previous study at Loyola demonstrated that the presence of activated NKT cells slows down the healing process, while the absence of these cells leads to faster wound closure.

In an editorial, Kovacs and colleagues wrote that since neutrophils and NKT cells are among the earliest immune system responders to injury, "they serve as ideal targets for modulation of the wound-repair process." For example, in experimental models, treatment with antibodies against surface molecules on neutrophils or NKT cell
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Experimental Drug Offers Hope for Cystic Fibrosis Patients
2. Experimental Vaccine Shields Monkeys Against Ebola
3. Experimental targeted therapy shows early promise against medulloblastomas
4. Experimental nonsteroidal treatment of asthma shows promise
5. Experimental obesity drug avoids brain effects that troubled predecessors
6. Experimental treatments for cocaine addiction may prevent relapse
7. Experimental TB Test Called Fast and Accurate
8. Experimental Drug Shows Promise for Bone Marrow Disorder
9. Experimental Leukemia Drug Proves a Slam Dunk
10. Experimental Test May Spot Prostate Cancer Earlier, More Accurately
11. Experimental Drug Aids Kids With Nervous System Tumor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... For thirteen years, the Twin Cities DI Day ... in the nation! This year, on May 5th, 2015, Secura ... take DI Day on the road by supporting the first ... RHU, DIA, CLTC, Chief Executive Officer at Secura Consultants and ... change by stating, "The first Twin Cities DI Day was ...
(Date:4/24/2015)... As the nation recognizes the Month of the ... young men and women, the “Alaska – Forget Me ... presents a special training session on Adverse Childhood Experiences ... understanding of the effect of childhood trauma and, in ... and military – who provide services and support to ...
(Date:4/24/2015)... 2015 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... federal multidistrict litigation underway in U.S. District Court, ... the parties involved in the proceeding submitted a ... other things, preparation for the litigation’s upcoming bellwether ... plaintiffs and defendants have conducted depositions of non-party ...
(Date:4/24/2015)... 2015 Lowcostcarinsuranceprice.com has released a new ... auto insurance for senior citizens . , Senior ... does not mean that they cannot find affordable coverage. ... can find the right coverage for their cars at ... like http://lowcostcarinsuranceprice.com/ provides free leads from various ...
(Date:4/24/2015)... Olive Fertility Centre is proud to ... co-director, has been honoured for his pioneering work in ... Hope Gala. , “We are very pleased to ... has been at the forefront of fertility research and ... Executive Director of Fertile Futures--a Canadian non-profit organization that ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Takes DI Day On The Road 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2
... This release is available in Spanish . ... acuity, between now and the year 2020, more and more ... age-related macular degeneration (AMD) and other sight-robbing diseases. ... Nutrition and Vision Research are finding that healthy eating can ...
... because of the potential to provide more durable and widespread ... cells. Now, researchers at Children,s Hospital Boston and their colleagues ... most common form of human lung cancer and, more significantly, ... tumor to tumor, depending upon the tumor,s genetic signature. ...
... , THURSDAY, July 1 (HealthDay News) -- ... uterine fibroids and helps women with the non-cancerous tumors ... pain and heavy menstrual bleeding, are a leading cause ... "Both the fibroids and the surgical interventions commonly used ...
... ... campaign is the first of its kind for designer and includes the ... cities across the country, national advertising, a bus wrap in Chicago, and ... colors and styles on July 8th, Vera Bradley is encouraging people across ...
... The Parkinson,s Disease Foundation (PDF) is pleased to announce ... understand the cause(s) of and find a cure for ... the work of 15 leading scientists and are provided ... and Research Fellowship Grants. The first program seeks ...
... ... Together to Share Ideas and Innovate , ... Braintree, MA (PRWEB) July 1, 2010 -- WorldAPP, a global on-demand web-application company, ... can come together to share ideas about all aspects of the data collection process. , ...
Cached Medicine News:Health News:Cancer stem cells are not 1 size fits all, lung cancer models show 2Health News:Drug May Shrink Fibroids, Preserve Fertility 2Health News:Vera Bradley Launches National “Be Colorful” Campaign 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 3Health News:WorldAPP Launches User Community 2Health News:WorldAPP Launches User Community 3
(Date:4/24/2015)... , Apr. 24, 2015 Research and Markets ... of the "Global Biobanking Market 2015-2019" report ... Global Biobanking market to grow at a CAGR of ... Biobanking market can be divided into two segments: Equipment ... the growth prospects of the Global Biobanking market for ...
(Date:4/24/2015)... 24, 2015 The National Institute of ... National Institutes of Health [NIH])  provided grants totaling ... for the development of diagnostic tests for antibiotic-resistant ... at U.S. health facilities , the NIAID and ... multiplexed and effective tests using alternative methods to ...
(Date:4/24/2015)... Hospira, Inc. (NYSE: HSP ... therapies, spoke about the importance of extrapolation in bringing ... (EGA) annual European Biosimilars Group conference in ... the publication of a pivotal white paper titled, ... of biosimilars." Speaking at the EGA ...
Breaking Medicine Technology:Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7
... - Additional data reinforce long-term efficacy of ACTEMRA ... - , , , NUTLEY, N.J., June ... LITHE (Toci LI zumab Safety and THE ... greater proportion of rheumatoid arthritis (RA) patients treated with ...
... Issue of Circulation , , SILVER SPRING, Md. ... UTHR ) and Eli Lilly and Company ... of a pivotal 16-week study showing that a once-daily ... capacity and improved time to clinical worsening in patients ...
Cached Medicine Technology:Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 2Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 3Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 5Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 6Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 7Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 8Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 2Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 3Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 4Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 5Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 6
Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies....
Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
... one-piece baseplate is designed specifically ... thicker than the current Assura, ... erosion for longer. The product ... piece and two piece, both ...
... kit for the screening of factor-V-related APC ... the test for the factor V:Q506 mutation ... with an excess of V-DEF Plasma bioreagent. ... discriminate between heterozygous and homozygous factor V ...
Medicine Products: